Aldeyra Therapeutics, Inc. (ALDX)
4.95
-0.13
(-2.56%)
USD |
NASDAQ |
Feb 20, 16:00
4.95
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics SG&A Expense (Quarterly) : 2.570M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 10.74M |
| MediciNova, Inc. | 1.554M |
| Altimmune, Inc. | 5.904M |
| Actinium Pharmaceuticals, Inc. | 1.534M |
| Avanos Medical, Inc. | 77.60M |